EU's Advisory Panel Clears MedImmune's Nasal Flu Vaccine; Restricts Use Of Fibrates
This article was originally published in The Pink Sheet Daily
Executive Summary
Europe's top advisory panel, CHMP, issues positive opinions on MedImmune's Fluenz, Lucentis in diabetic macular edema, Sprycel as first-line CML therapy, and Sutent in pancreatic cancer.